Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Commercializing cognitive neurotechnology—the ethical terrain

Nature Biotechnology volume 25, pages 393–397 (2007)Cite this article

Lack of recognition of the ethical, social and policy issues associated with the commercialization of neurotechnology could compromise new ventures in the area.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. http://www.europeanbraincouncil.org/ (accessed April 26, 2006).

  2. Illes, J., DeVries, R., Cho, M.K. & Schraedley-Desmond, P. Am. J. Bioeth. 6, 24–31 (2006).

    Article  Google Scholar 

  3. Eaton, M. & Kennedy, D. in Ethical Challenges in Medical Technology Innovation. p. 84–93 (Johns Hopkins University Press, Baltimore, 2007).

    Google Scholar 

  4. Fitzgerald, M. VCs psyched over brain investments. Venture Cap. J., published online 1 August 2005. <http://www.venturecapitaljournal.net/vcj/1122124806471.html>

  5. Gazzaniga, M. The Ethical Brain (The Dana Foundation Press, New York, 2005).

    Google Scholar 

  6. Illes, J. & Kirschen, M.P. AJNR Am. J. Neuroradiol. 24, 1932–1934 (2003).

    PubMed  Google Scholar 

  7. deCharms, R.C. et al. Proc. Natl. Acad. Sci. USA 102, 18626–18231 (2005).

    Article  CAS  PubMed  Google Scholar 

  8. Collie, A. & Maruff, P. Br. J. Sports Med. 37, 2–3 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Anderson, A.W. et al. Magn. Reson. Imaging 24, 693–697 (2006).

    Article  CAS  PubMed  Google Scholar 

  10. Caseras, X. et al. Psychosom. Med. 68, 947–955 (2006).

    Article  PubMed  Google Scholar 

  11. Tanaka, M. et al. BMC Neurol. 6, 9 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Canli, T. & Amin, Z. Brain Cogn. 50, 414–431 (2002).

    Article  PubMed  Google Scholar 

  13. Canli, T. Neuroethics: Defining the Issues in Theory, Practice and Policy. (ed. Illes, J.) 165–183 (Oxford University Press, Oxford, 2006).

    Google Scholar 

  14. Phelps, E.A. et al. J. Cogn. Neurosci. 12, 729–738 (2000).

    Article  CAS  PubMed  Google Scholar 

  15. Silberman, S. Wired Magazine 14, 14 (2006).

    Google Scholar 

  16. Farah, M.J. Nat. Neurosci. 5, 1123–1129 (2002).

    Article  CAS  PubMed  Google Scholar 

  17. Farah, M.J. et al. Nat. Rev. Neurosci. 5, 421–425 (2004).

    Article  CAS  PubMed  Google Scholar 

  18. Spence, S.A. et al. Neuroreport 12, 2849–2853 (2001).

    Article  CAS  PubMed  Google Scholar 

  19. Lee, T.M. et al. Hum. Brain Mapp. 15, 157–164 (2002).

    Article  PubMed  Google Scholar 

  20. Kozel, F.A. et al. Biol. Psychol. 58, 605–613 (2005).

    Article  Google Scholar 

  21. National Research Council. The Polygraph and Lie Detection. (National Academies Press, Washington, DC, 2003.) <http://darwin.nap.edu/books/0309084369/html> (accessed April 26, 2006).

  22. http://www.brainwavescience.com (accessed January 26, 2007).

  23. Temple, E. et al. Proc. Natl. Acad. Sci. USA 100, 2860–2865 (2003).

    Article  CAS  PubMed  Google Scholar 

  24. McClure, S.M. et al. Neuron 44, 379–387 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. http://members.forbes.com/forbes/2003/0901/062.html.

  26. Anonymous. Christ. Sci. Monit. January, p. 17 (2003).

  27. Lawton, G. New Scientist February, p. 18 (2006).

  28. Laurence, C. Sunday Telegraph (London) January, p. 5 (2005).

  29. Hoag, H. Nature 423, 796–798 (2003).

    Article  CAS  PubMed  Google Scholar 

  30. President's Bioethics Council. Better Memories: The Promise and Perils of Pharmacological Interventions. (President's Council on Bioethics, HarperCollins, Washington, DC, 2003).

  31. Illes, J. Cerebrum 6, 73–80 (2004).

    PubMed  Google Scholar 

  32. Greely, H.T. Regan lecture (Markkula Center for Applied Ethics, Santa Clara University, Santa Clara, CA, 2004).

    Google Scholar 

  33. Schuman, D. Comment on: J. Illes. Authenticity, bluffing and the privacy of human thought (Lecture presented at the University of Texas, Dallas, January 9, 2007).

    Google Scholar 

  34. http://www.nytimes.com/2004/04/20/science/20SCAN.html?pagewanted=1&ei=5007&en=20e627931944313d&ex=1397880000&partner=USERLAND

  35. Quackwatch: A skeptical view of SPECT scans and Dr. Daniel Amen. http://www.quackwatch.org/06ResearchProjects/amen.html

  36. Kennedy, D. in Neuroethics: Mapping the Field, vol. 1. (ed. Marcus, S.J.) 193–207 (The Dana Press, San Francisco, 2002).

    Google Scholar 

  37. Illes, J. & Racine, E. Am. J. Bioeth. 5, W3–W4 (2005).

    Article  Google Scholar 

  38. Illes, J., Kirschen, M.P. & Gabrieli, J.D. Nat. Neurosci. 6, 205 (2003).

    Article  CAS  PubMed  Google Scholar 

  39. Olsen, S. Science 307, 1548–1550 (2005).

    Article  Google Scholar 

  40. http://www.cognitiveliberty.org/ (accessed April 26, 2006).

  41. Moreno, J.D. Nat. Rev. Neurosci. 4, 149–153 (2003).

    Article  CAS  PubMed  Google Scholar 

  42. Childress, A.R. et al. Am. J. Psychiatry 156, 11–18 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gray, A.J. J. R. Soc. Med. 95, 72–76 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

  44. Illes, J. et al. Radiology 228, 346–351 (2003).

    Article  PubMed  Google Scholar 

  45. Lin, Z., Owen, A.B. & Altman, R. Science 305, 183 (2004).

    Article  CAS  PubMed  Google Scholar 

  46. NHGRI. Promoting safe and effective genetic testing in the United States. <http://biotech.law.lsu.edu/research/fed/tfgt> (accessed October 10, 2005).

  47. Bookheimer, S.Y. et al. N. Engl. J. Med. 343, 450–456 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Jack, C.R. et al. Neurology 60, 253–260 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  49. Albert, M. The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment. Working Report: Neuroimaging Workgroup of the Alzheimer's Association (Alzheimer's, Chicago, IL. 2005).

    Google Scholar 

  50. Collins, F.S. N. Engl. J. Med. 34, 186–188 (1996).

    Article  Google Scholar 

  51. Wadman, M. The DNA hard sell. New York Times Dec. 16, p. A15 (1996).

  52. Saltus, R. Gene test for cancer risk is offered; some geneticists dispute its value. Boston Globe Oct. 25, p. QA1 (1996).

  53. Illes, J., Rosen, A.C., Grecius, M. & Racine, E. Prospects for prediction: an ethics analysis of neuroimaging in Alzheimer's Disease. Ann. NY Acad. Sci. 1097, 278–295 (2007).

    Article  CAS  PubMed  Google Scholar 

  54. Leshner, A. Am. J. Bioeth. 5, 1–2 (2005).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Judy Illes's contribution is supported by NIH National Institutes of Neurological Disorders and Stroke no. 045831. Don DuRousseau is gratefully acknowledged for his support and comments on this manuscript.

Author information

Authors and Affiliations

  1. Margaret L. Eaton is at the Graduate School of Business, Stanford University, 518 Memorial Way, Stanford, California 94305-5615, USA. illes@stanford.edu,

    Margaret L Eaton

  2. Department of Pediatrics (Medical Genetics), Judy Illes is at the Stanford Center for Biomedical Ethics, 701 Welch Road, Building A, Suite 1105, Palo Alto, California 94304-5748, USA.,

    Judy Illes

Authors
  1. Margaret L Eaton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy Illes
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

J.I. is a pro bono ethics advisor to Human Bionics, a neurotechnology firm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eaton, M., Illes, J. Commercializing cognitive neurotechnology—the ethical terrain. Nat Biotechnol 25, 393–397 (2007). https://doi.org/10.1038/nbt0407-393

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0407-393

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing